Stand Up To Cancer - Science Leadership: Phillip A. Sharp

Science Leadership

Who We Are  >  Science Leadership

Stand Up To Cancer is backed by a driven and collaborative group of researchers and scientific advisors who make incredible research breakthroughs possible.

SCIENTIFIC ADVISORY COMMITTEE

Chaired by Nobel laureate Phillip A. Sharp, PhD, SU2C’s Scientific Advisory Committee is comprised of highly accomplished researchers, physicians and patient advocates.

Phillip A. Sharp, PhD
 | 
Chair

Institute Professor
Koch Institute for Integrative Cancer Research
Massachusetts Institute of Technology

 

View Bio | View Institution

Elizabeth H. Blackburn, PhD
 | 
Vice Chair

Professor Emerita, Department of Biochemistry and Biophysics
University of California San Francisco

 

View Bio | View Institution

Raymond N. DuBois, MD, PhD
 | 
Vice Chair

Director, Hollings Cancer Center
Dean, College of Medicine
Medical University of South Carolina

 

View Bio | View Institution

Lee J. Helman, MD
 | 
Vice Chair

Director, Osteosarcoma Institute
Adjunct Clinical Professor of Pediatrics
Cancer and Blood Disease Institute
CHLA, Keck School of Medicine,
University of Southern California

 

View Bio | View Institution

Arnold J. Levine, PhD
 | 
Vice Chair

Professor Emeritus
Institute for Advanced Study and
Cancer Institute of New Jersey

 

View Bio | View Institution

William G. Nelson, MD, PhD
 | 
Vice Chair

Director, Sidney Kimmel Comprehensive
Cancer Center
Johns Hopkins University

 

View Bio | View Institution

Edith A. Perez, MD
 | 
Vice Chair

Chief Medical Officer, Bolt Biotherapeutics
Professor of Medicine, Mayo Clinic

 

View Bio | View Institution

Carlos L. Arteaga, MD

Lisa K. Simmons Distinguished Chair in
Comprehensive Oncology
UT Southwestern Harold C. Simmons
Cancer Center

 

View Institution

Alan Bernstein, PhD

President and CEO
Canadian Institute for Advanced Research

 

View Institution

John D. Carpten, PhD

Chief Scientific Officer
Director, Comprehensive Cancer Center
Director, Beckman Research Institute
City of Hope

 

View Institution

Judy E. Garber, MD, MPH

Chief, Division for Cancer Genetics and Prevention
Dana-Farber Cancer Institute

 

View Institution

Richard B. Gaynor, MD

President, Research and Development
BioNTech US Inc.

 

View Institution

Laurie H. Glimcher, MD

President and CEO
Dana-Farber Cancer Institute

 

View Institution

Nancy F. Goodman, JD

Executive Director and Founder
Kids v Cancer

 

View Institution

James L. Gulley, MD, PhD

Center for Cancer Research
National Cancer Institute

 

View Institution

William N. Hait, MD, PhD

Global Head of External Innovation
Janssen, Pharmaceutical Companies of Johnson & Johnson

 

View Institution

Waun Ki Hong, MD
 | 
(In Memorium)

The University of Texas MD
Anderson Cancer Center

 

View Institution

William G. Kaelin, Jr., MD

Sidney Farber Professor of Medicine,
Harvard Medical School
Dana-Farber Cancer Institute

 

View Institution

Michael B. Kastan, MD, PhD

Director
Duke Cancer Institute

 

View Institution

Guillermina (Gigi) Lozano, PhD

Chairman and Professor
University of Texas MD Anderson
Cancer Center

 

View Institution

Tak W. Mak, PhD

Chief Scientific Officer
Campbell Family Institute

 

View Institution

Andre Nussenzweig, PhD

Chief, Laboratory of Genome Integrity
NIH Distinguished Investigator
Center for Cancer Research National
Cancer Institute

 

View Institution

Roderic I. Pettigrew, PhD, MD

Chief Executive Officer,
Engineering Health (EnHealth)
Executive Dean
Texas A&M University

 

View Institution

Cecil B. Pickett, PhD (Retired)

President, R&D (Retired)
Biogen Inc.

 

View Institution

Arlene Sharpe, MD, PhD

George Fabyan Professor
of Comparative Pathology
Co-Director, Harvard Institute of
Translational Immunology
Co-Director, Evergrande Center for
Immunologic Diseases Harvard Medical School

 

View Institution

Laura K. Shawver, PhD

President and Chief Executive Officer
Capstan Therapeutics

 

View Institution

David A. Tuveson, MD, PhD

Professor and Director
Cold Spring Harbor Laboratory Cancer Center

 

View Institution

Canada Scientific Advisory Committee (CSAC)

Alan Bernstein, PhD
 | 
Co-chairperson

President & CEO
Canadian Institute for Advanced Research

 

View Bio | View Institution

Phillip A. Sharp, PhD
 | 
Co-chairperson

Institute Professor
Koch Institute for Integrative Cancer Research
Massachusetts Institute of Technology

 

View Bio | View Institution

Carlos L. Arteaga, MD

Lisa K. Simmons Distinguished Chair in
Comprehensive Oncology
UT Southwestern Harold C. Simmons
Cancer Center

 

View Institution

Jenny C. Chang, MD

Emily Herrmann Chair in Cancer Research
and Director
Methodist Cancer Center at Houston
Methodist Hospital

 

View Institution

Carol Prives, PhD

DaCosta Professor
​Columbia University

 

View Institution

Patrick Sullivan

Advocate President
Team Finn Foundation

 

View Institution

SU2C Committee for Health Equity In Cancer Clinical Trials (HEC)

Edith A. Perez, MD
 | 
Chair

Chief Medical Officer, Bolt Biotherapeutics
Professor of Medicine, Mayo Clinic

 

View Bio | View Institution

John D. Carpten, PhD

Chief Scientific Officer
Director, Comprehensive Cancer Center
Director, Beckman Research Institute
City of Hope

 

View Institution

Andrew T. Chan, MD, MPH

Professor of Medicine
Harvard Medical School

 

View Institution

Shawna Hudson, PhD

Professor and Research Division Chief,
Department of Family Medicine
and Community Health
Rutgers Robert Wood Johnson Medical School

 

View Institution

Chanita Hughes-Halbert, PhD

Vice Chair for Research and Professor,
Department of Population and Public Health Sciences
Associate Director for Cancer Equity
Norris Comprehensive Cancer Center
University of Southern California

 

View Institution

Elizabeth Jaffee, MD

Deputy Director
The Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins University

 

View Institution

Guillermina (Gigi) Lozano, PhD

Chairman and Professor
The University of Texas MD Anderson
Cancer Center

 

View Institution

John Whyte, MD, MPH

Chief Medical Officer
WebMD

 

View Institution

Raymond M. Williams, JD

Senior Counsel
DLA Piper

 

View Institution

David R. Wilson, PhD

Director of the Tribal Health Research Office
National Institutes of Health

 

View Institution

Karen Winkfield, MD, PhD

Executive Director
Meharry-Vanderbilt Alliance

 

View Institution

Robert A. Winn, MD

Director
Massey Cancer Center
Virginia Commonwealth University

 

View Institution

SU2C Catalyst Executive Committee

Phillip A. Sharp, PhD

Institute Professor
Koch Institute for Integrative Cancer Research
Massachusetts Institute of Technology

 

View Institution

Lee J. Helman, MD

Director, Osteosarcoma Institute
Adjunct Clinical Professor of Pediatrics
Cancer and Blood Disease Institute
CHLA, Keck School of Medicine,
University of Southern California

 

View Institution

Arnold J. Levine, PhD

Professor Emeritus
Institute for Advanced Study and
Cancer Institute of New Jersey

 

View Institution

William G. Nelson, MD, PhD

Director, Sidney Kimmel Comprehensive
Cancer Center
Johns Hopkins University

View Institution

Cecil B. Pickett, PhD

President, R&D (Retired)
Biogen Inc.

View Institution

Lillian L. Siu, MD

Senior Scientist
Princess Margaret Cancer Centre
View Institution

Pediatric SU2C Catalyst Executive Committee

Phillip A. Sharp, PhD

Institute Professor
Koch Institute for Integrative Cancer Research
Massachusetts Institute of Technology

 

View Institution

Alan D. D’Andrea, MD

Fuller-American Cancer Society Professor of Radiation Oncology
Harvard Medical School
Director of the Center for DNA Damage and Repair and
Director of the Susan F. Smith Center for Women’s Cancers
Dana-Farber Cancer Institute

View Institution

Lisa R. Diller, MD

Chief Medical Officer
Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
Vice Chair
Department of Pediatric Oncology
Dana-Farber Cancer Institute
View Institution

Raymond N. DuBois, MD, PhD

Director, Hollings Cancer Center
Dean, College of Medicine
Medical University of South Carolina

 

View Institution

Arnold J. Levine, MD

Professor Emeritus
Institute for Advanced Study and
Cancer Institute of New Jersey

 

View Institution

RESEARCHERS

SU2C’s scientists are the most capable, passionate and dedicated in their respective fields. This group of extraordinary individuals is constantly pushing towards progress, thus allowing for revolutionary discoveries. SU2C is supported by a team of more than 3,000 scientists from more than 210 prestigious medical and educational institutions that are united under one cause to end cancer as we know it.

Dream Teams, Research Teams, SU2C Convergence Teams, SU2C Catalyst® Teams, and through Innovative Research Grants.

RESEARCH PORTFOLIO

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.